Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Earl Hubbell

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
British Journal of Cancer|May 15, 2023
Modelled mortality benefits of multi-cancer early detection screening in EnglandPeter Sasieni, Rebecca Smittenaar, Earl Hubbell, et al.
British Journal of Cancer|November 18, 2024
Correction: Modelled mortality benefits of multi-cancer early detection screening in EnglandPeter Sasieni, Rebecca Smittenaar, Earl Hubbell, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 29, 2023
Potential for Cure by Stage across the Cancer Spectrum in the United StatesEarl Hubbell, Christina A Clarke, Karin E Smedby, et al.
Journal of Medical Screening|February 2, 2024
Clinical performance and utility: A microsimulation model to inform the design of screening trials for a multi-cancer early detection testJames Y Dai, Jing Zhang, Jerome V Braun, et al.
Journal of Epidemiology and Community Health|March 1, 2024
Impact of screening participation on modelled mortality benefits of a multi-cancer early detection test by socioeconomic group in EnglandRebecca Smittenaar, Samantha L Quaife, Christian von Wagner, et al.
Cancer Medicine|March 17, 2025
Estimating the Burden of False Positives and Implementation Costs From Adding Multiple Single Cancer Tests or a Single Multi-Cancer Test to Standard-Of-Care ScreeningSarina Madhavan, Allan Hackshaw, Earl Hubbell, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 23, 2021
Racial/Ethnic Differences in Cancer Diagnosed after Metastasis: Absolute Burden and Deaths Potentially Avoidable through Earlier DetectionChristina A Clarke, Alpa V Patel, Allison W Kurian, et al.
Cancer Causes & Control : CCC|January 18, 2024
Avoiding lead-time bias by estimating stage-specific proportions of cancer and non-cancer deathsEllen T Chang, Christina A Clarke, Graham A Colditz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 2, 2020
Projected Reductions in Absolute Cancer-Related Deaths from Diagnosing Cancers Before Metastasis, 2006-2015Christina A Clarke, Earl Hubbell, Allison W Kurian, et al.
JCO Precision Oncology|March 12, 2026
Prognostic Significance of Blood-Based Multicancer Detection in Circulating Tumor DNA: Five-Year Outcomes AnalysisCharles Swanton, Alan Bryce, Allen L Cohn, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
British Journal of Cancer|May 15, 2023
Modelled mortality benefits of multi-cancer early detection screening in EnglandPeter Sasieni, Rebecca Smittenaar, Earl Hubbell, et al.
British Journal of Cancer|November 18, 2024
Correction: Modelled mortality benefits of multi-cancer early detection screening in EnglandPeter Sasieni, Rebecca Smittenaar, Earl Hubbell, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 29, 2023
Potential for Cure by Stage across the Cancer Spectrum in the United StatesEarl Hubbell, Christina A Clarke, Karin E Smedby, et al.
Journal of Medical Screening|February 2, 2024
Clinical performance and utility: A microsimulation model to inform the design of screening trials for a multi-cancer early detection testJames Y Dai, Jing Zhang, Jerome V Braun, et al.
Journal of Epidemiology and Community Health|March 1, 2024
Impact of screening participation on modelled mortality benefits of a multi-cancer early detection test by socioeconomic group in EnglandRebecca Smittenaar, Samantha L Quaife, Christian von Wagner, et al.
Cancer Medicine|March 17, 2025
Estimating the Burden of False Positives and Implementation Costs From Adding Multiple Single Cancer Tests or a Single Multi-Cancer Test to Standard-Of-Care ScreeningSarina Madhavan, Allan Hackshaw, Earl Hubbell, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 23, 2021
Racial/Ethnic Differences in Cancer Diagnosed after Metastasis: Absolute Burden and Deaths Potentially Avoidable through Earlier DetectionChristina A Clarke, Alpa V Patel, Allison W Kurian, et al.
Cancer Causes & Control : CCC|January 18, 2024
Avoiding lead-time bias by estimating stage-specific proportions of cancer and non-cancer deathsEllen T Chang, Christina A Clarke, Graham A Colditz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 2, 2020
Projected Reductions in Absolute Cancer-Related Deaths from Diagnosing Cancers Before Metastasis, 2006-2015Christina A Clarke, Earl Hubbell, Allison W Kurian, et al.
JCO Precision Oncology|March 12, 2026
Prognostic Significance of Blood-Based Multicancer Detection in Circulating Tumor DNA: Five-Year Outcomes AnalysisCharles Swanton, Alan Bryce, Allen L Cohn, et al.
Pageof 5